|
業務類別
|
-- |
|
業務概覽
|
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public healthpreparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif. |
| 公司地址
| Philip Heymans Alle 3, Hellerup, DNK, 2900 |
| 電話號碼
| +45 33268383 |
| 傳真號碼
| +45 33268380 |
| 公司網頁
| https://www.bavarian-nordic.com |
| 員工數量
| 1653 |
| Mr. Paul Chaplin |
President and Chief Executive Officer |
-- |
05/03/2025 |
| Mr. Henrik Juuel |
Executive Vice President and Chief Financial Officer |
-- |
05/03/2025 |
|
|
| Mr. Anders Gersel Pedersen, M.D.,PhD |
Deputy Chairman of the Board |
05/03/2025 |
| Dr. Frank Verwiel, M.B.A.,M.D. |
Independent Director |
05/03/2025 |
| Ms. Heidi Hunter |
Independent Director |
05/03/2025 |
| Ms. Anne Louise Eberhard, M. Sc. |
Independent Director |
05/03/2025 |
| Mr. Johan van Hoof |
Independent Director |
05/03/2025 |
| Mr. Luc Debruyne |
Chairman of the Board |
05/03/2025 |
| Ms. Montse Montaner |
Independent Director |
05/03/2025 |
| Ms. Linette Munksgaard Andersen |
Director |
05/03/2025 |
| Ms. Anja Gjol |
Director |
05/03/2025 |
| Mr. Thomas Alex Bennekov |
Director |
05/03/2025 |
| Ms. Karen Merete Jensen |
Director |
05/03/2025 |
|
|
|
|
